Years of proprietary research into the role of breast milk and its impact on human development led to our groundbreaking discovery of B. infantis EVC001, a natural bacterial strain foundational to infant immune health. Unfortunately, B. infantis had been almost completely eradicated from infants in developed countries due to unintended consequences of modern medicine such as feeding and birthing practices. Now, there is a way to change that. What we found is that EVC001, our specific strain of B. infantis, is essential in developing a healthy microbiome.
We believe the greatest chance to impact future health begins early, right after birth—a once in a lifetime opportunity where rapid development and radical changes occur. By unlocking human nutrition's full potential through introducing beneficial bacteria during early infancy, we can help build a foundation for better health.
A spin-out from the Foods For Health Institute (FFHI) at the University of California, Davis, we are now a leader aiming to improve individual health through diet and the gut microbiome. Our founding scientists continue to advise and collaborate with us, sharing their experience from more than a decade of research into the infant gut microbiome and its critical interaction with breast milk.
Food Scientist. Distinguished Professor, UC Davis Food Science & Technology
Gastrointestinal Physiologist, Founder & Executive Director, Regulatory Affairs & Intellectual Property
Microbiologist, Distinguished Professor, UC Davis Food Science & Technology and Viticulture & Enology
Whether babies receive breast milk or are mix-fed with formula, our current product portfolio supports babies along their feeding journey, starting with the first feed through their transition away from drinking breast milk.
Exclusively for Healthcare Settings
|Ready-to-use, single-serve liquid made specifically for use in healthcare settings, clinically shown to help stabilize and protect the infant gut microbiome.|